Literature DB >> 23493725

Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model.

Chris L McGowin1, Andrea L Radtke, Kyle Abraham, David H Martin, Melissa Herbst-Kralovetz.   

Abstract

BACKGROUND: Because Mycoplasma genitalium is a prevalent and emerging cause of sexually transmitted infections, understanding the mechanisms by which M. genitalium elicits mucosal inflammation is an essential component to managing lower and upper reproductive tract disease syndromes in women.
METHODS: We used a rotating wall vessel bioreactor system to create 3-dimensional (3-D) epithelial cell aggregates to model and assess endocervical infection by M. genitalium.
RESULTS: Attachment of M. genitalium to the host cell's apical surface was observed directly and confirmed using immunoelectron microscopy. Bacterial replication was observed from 0 to 72 hours after inoculation, during which time host cells underwent ultrastructural changes, including reduction of microvilli, and marked increases in secretory vesicle formation. Using genome-wide transcriptional profiling, we identified a host defense and inflammation signature activated by M. genitalium during acute infection (48 hours after inoculation) that included cytokine and chemokine activity and secretion of factors for antimicrobial defense. Multiplex bead-based protein assays confirmed secretion of proinflammatory cytokines, several of which are involved in leukocyte recruitment and hypothesized to enhance susceptibility to human immunodeficiency type 1 infection.
CONCLUSIONS: These findings provide insight into key molecules and pathways involved in innate recognition of M. genitalium and the response to acute infection in the human endocervix.

Entities:  

Keywords:  Mycoplasma; Mycoplasma genitalium; cervix; endocervix; epithelial; immune response; sexually transmitted infection; transcriptome

Mesh:

Substances:

Year:  2013        PMID: 23493725      PMCID: PMC3654750          DOI: 10.1093/infdis/jit101

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya.

Authors:  Craig R Cohen; Marcianna Nosek; Amalia Meier; Sabina G Astete; Stefanie Iverson-Cabral; Nelly R Mugo; Patricia A Totten
Journal:  Sex Transm Dis       Date:  2007-05       Impact factor: 2.830

2.  Sequence-based typing of Mycoplasma genitalium reveals sexual transmission.

Authors:  Sofie Vetli Hjorth; Eva Björnelius; Peter Lidbrink; Lars Falk; Birthe Dohn; Lene Berthelsen; Liang Ma; David H Martin; Jørgen Skov Jensen
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences.

Authors:  Stefanie L Iverson-Cabral; Sabina G Astete; Craig R Cohen; Eduardo P C Rocha; Patricia A Totten
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Isolation of Mycoplasma genitalium strains from the male urethra.

Authors:  J S Jensen; H T Hansen; K Lind
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Identification and characterization of immunogenic proteins of mycoplasma genitalium.

Authors:  Helle Friis Svenstrup; Jørgen Skov Jensen; Kris Gevaert; Svend Birkelund; Gunna Christiansen
Journal:  Clin Vaccine Immunol       Date:  2006-08

6.  Mycoplasma genitalium P140 and P110 cytadhesins are reciprocally stabilized and required for cell adhesion and terminal-organelle development.

Authors:  Raul Burgos; Oscar Q Pich; Mario Ferrer-Navarro; Joel B Baseman; Enrique Querol; Jaume Piñol
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

7.  Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.

Authors:  Nigel Bourne; Richard B Pyles; MinKyung Yi; Ronald L Veselenak; Melissa M Davis; Stanley M Lemon
Journal:  Antiviral Res       Date:  2005-08       Impact factor: 5.970

8.  Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle.

Authors:  A Moriyama; K Shimoya; I Ogata; T Kimura; T Nakamura; H Wada; K Ohashi; C Azuma; F Saji; Y Murata
Journal:  Mol Hum Reprod       Date:  1999-07       Impact factor: 4.025

9.  Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia.

Authors:  Melissa M Herbst-Kralovetz; Alison J Quayle; Mercedes Ficarra; Sheila Greene; William A Rose; Ralph Chesson; Rae Ann Spagnuolo; Richard B Pyles
Journal:  Am J Reprod Immunol       Date:  2008-01-12       Impact factor: 3.886

10.  Interplay between mycoplasmas and host target cells.

Authors:  J B Baseman; M Lange; N L Criscimagna; J A Giron; C A Thomas
Journal:  Microb Pathog       Date:  1995-08       Impact factor: 3.738

View more
  27 in total

Review 1.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

Review 2.  Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age.

Authors:  Jennifer Barrila; Aurélie Crabbé; Jiseon Yang; Karla Franco; Seth D Nydam; Rebecca J Forsyth; Richard R Davis; Sandhya Gangaraju; C Mark Ott; Carolyn B Coyne; Mina J Bissell; Cheryl A Nickerson
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

3.  Experimental Infection of Pig-Tailed Macaques (Macaca nemestrina) with Mycoplasma genitalium.

Authors:  Gwendolyn E Wood; Dorothy L Patton; Peter K Cummings; Stefanie L Iverson-Cabral; Patricia A Totten
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

Review 4.  The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium.

Authors:  Chris L McGowin; Patricia A Totten
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

Review 5.  Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen.

Authors:  Harold C Wiesenfeld; Lisa E Manhart
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

6.  Histological Evidence of Chronic Mycoplasma genitalium-Induced Cervicitis in HIV-Infected Women: A Retrospective Cohort Study.

Authors:  Patricia M Dehon; Michael E Hagensee; Kimberly J Sutton; Hope E Oddo; Nia Nelson; Chris L McGowin
Journal:  J Infect Dis       Date:  2016-01-17       Impact factor: 5.226

7.  Human Three-Dimensional Endometrial Epithelial Cell Model To Study Host Interactions with Vaginal Bacteria and Neisseria gonorrhoeae.

Authors:  Paweł Łaniewski; Adriana Gomez; Geoffrey Hire; Magdalene So; Melissa M Herbst-Kralovetz
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 8.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

9.  Interleukin-36γ Is Elevated in Cervicovaginal Epithelial Cells in Women With Bacterial Vaginosis and In Vitro After Infection With Microbes Associated With Bacterial Vaginosis.

Authors:  Jameson K Gardner; Paweł Łaniewski; Anna Knight; Lisa B Haddad; Alison Swaims-Kohlmeier; Melissa M Herbst-Kralovetz
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226

10.  Veillonellaceae family members uniquely alter the cervical metabolic microenvironment in a human three-dimensional epithelial model.

Authors:  Mary E Salliss; Jason D Maarsingh; Camryn Garza; Paweł Łaniewski; Melissa M Herbst-Kralovetz
Journal:  NPJ Biofilms Microbiomes       Date:  2021-07-06       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.